Mu Dan Pi Wholesale High Quality Peony Root Bark

Name: Mu Dan Pi Wholesale High Quality Peony Root Bark
Brand: FUYANG BESTOP IMPEX CO., LTD.
SKU: 1914053855

Anhui, ChinaFUYANG BESTOP IMPEX CO., LTD.

US$45.00

1-99 kg

US$35.00

100+ kg

Sample price:US$45.00/kg.Request sample

Product profile

Customization

Available

Type

Crude Medicine

Medicine Property

Relaxing The Bowels

Model NO.

Peony Root Bark

Dosage

Soak in Boiling Water

Form

Wax

Part

bark

Storage Note

Insect Prevention

Chinese Name

Mu Dan Pi

English Name

Peony Root Bark

Latin Name

Cortex Moutan

Usage

Medicine,Health Food,Herbal Tea

Storage

Cool Dry Place

Shelf Life

2 Years

Certification

GMP, Brc, ISO, FDA, HACCP

Transport Package

50g/Bag, 1kg/Bag

Specification

slice

Trademark

FUYANG BESTOP

Origin

China

Production Capacity

10 Ton/Tons Per Month Gingseng

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceYears of Export ExperienceFast Delivery

FUYANG BESTOP IMPEX CO., LTD.

Anhui, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc.Export Year: 2011-08-18 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤7.39h

AI-Powered supplier vetting

SummaryThe supplier operates in traditional Chinese medicine, food, tea, household products, electronics, furniture, and related categories. It reports more than 10 production lines, 11–20 quality-control staff, and herbal-medicine output of 100 tons, but only one R&D engineer. ODM and OEM services are available, while no new product was developed during the past year. Service lead time is within 15 workdays in both off-season and peak season, although the supplier lacks inventory, overseas warehouses, showrooms, agents, and branches. Customer complaints have a clear procedure and records, but quality assurance, traceability, and sustainability documentation are unknown. R&D documentation and patents are absent, and no testing equipment is reported.

Supplier typeThe supplier is a diversified manufacturer and seller covering traditional Chinese medicine products, herbal medicine, tea, food, household goods, electronics, furniture, and children’s products. Its stated production setup includes more than 10 production lines, indicating a manufacturing-oriented supplier rather than a narrowly specialized service provider.

After-Sales capabilityThe supplier reports a clear customer-complaint procedure with follow-up records and lead times within 15 workdays in both peak and off-season. However, it has no in-stock service capacity, overseas warehouse, showroom, agent, or branch, and only some approved service-supplier names were provided; the absence of written corrective and preventive-action procedures is a documented weakness.

R&D capabilityInnovation evidence is weak: the supplier has one R&D engineer, no patents, no available R&D audit documentation, and no new product during the past year. Photoshop is listed as the only R&D software capability, although ODM service is available.

Production capacityThe supplier reports more than 10 production lines, 11–20 quality-control staff, and herbal-medicine output of 100 tons, with stated lead times within 15 workdays in both seasons. Nevertheless, it reports zero quality-control testing equipment, while quality-assurance and traceability statuses are unknown, limiting confidence in production controls.

Customization capabilityThe supplier provides technology support during production, prepares product specifications for client approval, and offers ODM and OEM services, including service for well-known brands. These statements explicitly support product customization capability despite limited R&D resources.

Client casesThe supplier states that it provides OEM services for well-known brands, which is evidence of at least some brand-customer experience. No customer names, project details, volumes, or independently verifiable case records are provided, so the depth of its customer portfolio remains unclear.